AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $309,000 | +31.5% | 6,500 | 0.0% | 0.02% | +18.8% |
| Q4 2018 | $235,000 | -41.2% | 6,500 | 0.0% | 0.02% | -30.4% |
| Q3 2018 | $400,000 | -8.9% | 6,500 | 0.0% | 0.02% | -11.5% |
| Q2 2018 | $439,000 | -64.3% | 6,500 | -71.3% | 0.03% | -66.7% |
| Q1 2018 | $1,229,000 | -9.2% | 22,650 | 0.0% | 0.08% | -8.2% |
| Q4 2017 | $1,353,000 | +61.5% | 22,650 | +31.3% | 0.08% | +30.8% |
| Q3 2017 | $838,000 | -53.8% | 17,250 | -50.0% | 0.06% | -55.8% |
| Q2 2017 | $1,813,000 | -20.8% | 34,500 | -31.7% | 0.15% | -22.6% |
| Q1 2017 | $2,290,000 | -27.1% | 50,500 | -39.2% | 0.19% | -34.7% |
| Q4 2016 | $3,142,000 | +0.3% | 83,000 | 0.0% | 0.29% | +0.7% |
| Q3 2016 | $3,132,000 | +57.5% | 83,000 | -26.5% | 0.29% | +21.9% |
| Q2 2016 | $1,989,000 | +44.8% | 113,000 | 0.0% | 0.24% | +23.4% |
| Q1 2016 | $1,374,000 | +182.1% | 113,000 | +465.0% | 0.19% | -11.1% |
| Q4 2015 | $487,000 | -16.8% | 20,000 | -39.4% | 0.22% | +137.4% |
| Q3 2015 | $585,000 | – | 33,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |